CEN

USPTO Trademark Record

ABANDONED

CENTANAFADINE SR IS A NOREPINEPHRINE- AND DOPAMINE-PREFERRING TRIPLE REUPTAKE INHIBITOR THAT HAS THE RIGHT RATIO FOR THE RIGHT PATIENT

Q: Who owns the CENTANAFADINE SR IS A NOREPINEPHRINE- AND DOPAMINE-PREFERRING TRIPLE REUPTAKE INHIBITOR THAT HAS THE RIGHT RATIO FOR THE RIGHT PATIENT trademark?

The CENTANAFADINE SR IS A NOREPINEPHRINE- AND DOPAMINE-PREFERRING TRIPLE REUPTAKE INHIBITOR THAT HAS THE RIGHT RATIO FOR THE RIGHT PATIENT trademark is owned by NEUROVANCE, INC..

Q: What class is the CENTANAFADINE SR IS A NOREPINEPHRINE- AND DOPAMINE-PREFERRING TRIPLE REUPTAKE INHIBITOR THAT HAS THE RIGHT RATIO FOR THE RIGHT PATIENT trademark registered in?

The CENTANAFADINE SR IS A NOREPINEPHRINE- AND DOPAMINE-PREFERRING TRIPLE REUPTAKE INHIBITOR THAT HAS THE RIGHT RATIO FOR THE RIGHT PATIENT trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

Q: What is the serial number for CENTANAFADINE SR IS A NOREPINEPHRINE- AND DOPAMINE-PREFERRING TRIPLE REUPTAKE INHIBITOR THAT HAS THE RIGHT RATIO FOR THE RIGHT PATIENT?

The USPTO serial number for CENTANAFADINE SR IS A NOREPINEPHRINE- AND DOPAMINE-PREFERRING TRIPLE REUPTAKE INHIBITOR THAT HAS THE RIGHT RATIO FOR THE RIGHT PATIENT is 86434375.

SN 86434375·Reg 0·Filed Sep 19, 2014

Owner NEUROVANCE, INC.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

CENTANAFADINE SR IS A NOREPINEPHRINE- AND DOPAMINE-PREFERRING TRIPLE REUPTAKE INHIBITOR THAT HAS THE RIGHT RATIO FOR THE RIGHT PATIENT (Serial No. 86434375), Registration No. 0, is a abandoned US trademark filed on Sep 19, 2014 by NEUROVANCE, INC.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

CENTANAFADINE SR IS A NOREPINEPHRINE- AND DOPAMINE-PREFERRING TRIPLE REUPTAKE INHIBITOR THAT HAS THE RIGHT RATIO FOR THE RIGHT PATIENT (Reg. #0) is an abandoned US trademark that was filed in 2014 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 19, 2014

SERIAL

86434375

REG#

Owner

Applicant

NEUROVANCE, INC.

Entity

Corporation

State

Address

508 Carnegie Center Drive, Princeton, MA, 08540

Country

Attorney

NameMichael P. Straher

Law firm

Michael P. Straher Hoxie & Associates LLC

Docket

EB-47-TM

Address

75 Main Street, Suite 203, Millburn, NJ 07041, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateSep 19, 2014

Serial Number86434375

Registration No.0

Status DateJul 09, 2018

Published for OppositionApr 07, 2015

Mark TypeStandard characters

Attorney DocketEB-47-TM

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2014

YEARS AGO

12y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

48 events

ABANDONMENT - NO USE STATEMENT FILED

Jul 09, 2018

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

Jul 09, 2018

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 08, 2017

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 07, 2017

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 5 GRANTED

Dec 07, 2017

SOU EXTENSION 5 GRANTED

SOU TEAS EXTENSION RECEIVED

Dec 01, 2017

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

Dec 01, 2017

SOU EXTENSION 5 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 06, 2017

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jun 02, 2017

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 FILED

Jun 02, 2017

SOU EXTENSION 4 FILED

SOU EXTENSION 4 GRANTED

Jun 02, 2017

SOU EXTENSION 4 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 20, 2016

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 3 GRANTED

Dec 19, 2016

SOU EXTENSION 3 GRANTED

SOU TEAS EXTENSION RECEIVED

Dec 02, 2016

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Dec 02, 2016

SOU EXTENSION 3 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 09, 2016

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 GRANTED

Jul 08, 2016

SOU EXTENSION 2 GRANTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jul 05, 2016

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jun 27, 2016

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jun 27, 2016

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 02, 2016

TEAS CHANGE OF CORRESPONDENCE RECEIVED

SOU TEAS EXTENSION RECEIVED

Jun 02, 2016

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Jun 02, 2016

SOU EXTENSION 2 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 04, 2015

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Dec 02, 2015

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Dec 02, 2015

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Dec 02, 2015

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 02, 2015

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 07, 2015

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 07, 2015

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 18, 2015

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

Mar 03, 2015

ASSIGNED TO LIE

LAW OFFICE PUBLICATION REVIEW COMPLETED

Mar 03, 2015

LAW OFFICE PUBLICATION REVIEW COMPLETED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 11, 2015

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT E-MAILED

Feb 11, 2015

EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Feb 11, 2015

EXAMINERS AMENDMENT -WRITTEN

EXAMINER'S AMENDMENT ENTERED

Feb 11, 2015

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 11, 2015

APPROVED FOR PUB - PRINCIPAL REGISTER

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Feb 06, 2015

PREVIOUS ALLOWANCE COUNT WITHDRAWN

WITHDRAWN FROM PUB - OG REVIEW QUERY

Jan 27, 2015

WITHDRAWN FROM PUB - OG REVIEW QUERY

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 06, 2015

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Jan 05, 2015

ASSIGNED TO EXAMINER

ASSIGNED TO PETITION STAFF

Nov 17, 2014

ASSIGNED TO PETITION STAFF

REQUEST TO CORRECT FILING DATE - GRANTED

Nov 17, 2014

REQUEST TO CORRECT FILING DATE - GRANTED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 04, 2014

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 28, 2014

NEW APPLICATION ENTERED

FAX RECEIVED

Oct 24, 2014

FAX RECEIVED

REQUEST TO CORRECT FILING DATE RECEIVED

Oct 24, 2014

REQUEST TO CORRECT FILING DATE RECEIVED

CENTANAFADINE SR IS A NOREPINEPHRINE- AND DOPAMINE-PREFERRING TRIPLE REUPTAKE INHIBITOR THAT HAS THE RIGHT RATIO FOR THE RIGHT PATIENT

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by NEUROVANCE, INC.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Michael P. Straher

Resources

Company